Companies / BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc.

Nasdaq: BBOTCIK 1869105SOUTH SAN FRANCISCO, CA

Financials

Revenue—
Net income$-134.04M
Total debt—
Cash$54.06M
Diluted EPS$-4.30
Shares outstanding80.2M

Ownership

80.2M shares outstanding · as of Aug 6, 2026
0.15%Insiders
Ownership
Insiders0.15%116,670
Institutions74.08%59,391,012
Public float25.78%20,666,585

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Beltran PedroChief Scientific Officer
0.06%46,670
Ben YongChief Med & Dev Officer
0.06%46,670
Mehra UneekChief Financial Officer
0.03%23,330
Lebowitz Peter FDirector
——
McCormick FrankDirector
——
Wallace Eli M.CEOChief Executive Officer · Director
——

Institutional holders 57

View all →
HolderValue% of shares
Cormorant Asset Management, LP$223.84M22.30%
Deerfield Management Company, L.P.$43.72M6.09%
Omega Fund Management, LLC$41.19M4.10%
Wellington Management Group LLP$36.40M3.63%
EcoR1 Capital, LLC$35.35M3.52%
Enavate Sciences GP, LLC$32.89M3.28%
Citadel Advisors LLC$31.68M3.16%
Catalio Capital Management, LP$31.41M0.51%
Paradigm BioCapital Advisors LP$28.32M2.82%
Alphabet Inc.$21.51M3.52%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 10, 2026Mehra Uneek
Executive
GrantCommon Stock$0+23K
23,330
0.03% of shares
low
Mar 10, 2026Beltran Pedro
Executive
GrantCommon Stock$0+47K
46,670
0.06% of shares
low
Mar 10, 2026Ben Yong
Executive
GrantCommon Stock$0+47K
46,670
0.06% of shares
low
Jun 16, 2026McCormick Frank
Director
GrantStock Option (Right to Buy)—+32K
31,675
0.04% of shares
low
Mar 24, 2026Lebowitz Peter F
Director
GrantStock Option (Right to Buy)—+63K
63,350
0.08% of shares
low
Mar 10, 2026Mehra Uneek
Executive
GrantStock Option (Right to Buy)—+105K
105,000
0.13% of shares
low
Mar 10, 2026Beltran Pedro
Executive
GrantStock Option (Right to Buy)—+210K
210,000
0.26% of shares
low
Mar 10, 2026Ben Yong
Executive
GrantStock Option (Right to Buy)—+210K
210,000
0.26% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BBOTCommon StockEquity107924102BBG01L3GYF02